Redeye comments on Better Collective’s Q3-results which came in somewhat lower than expected while t...
Redeye comments on Starbreeze robust Q3 2022 were both sales and profit levels were stronger than ex...
Redeye concludes that Q3 showed weak financials due to delay in the Saudi order, higher OPEX due to ...
According to Redeye, the Q3 report was mixed with lower-than-expected top line but in line in terms ...
Redeye comments on EG7’s Q3-results which came in much stronger than expected thanks to strong perfo...
Redeye has a neutral view of the directed share issue announced yesterday as increased M&A firepower...
Redeye is pleased that Paxman announced yesterday that the Paxman Limb Cryocompression System (PLCS)...
Fragbite Group: Stronger sales than expected
Redeye updates its estimates and fair value range following Arise’s Q3 report, where reported EBITDA...
Redeye updates its estimates on the back of I-Tech’s Q3’22 report, beating our estimates again.
Redeye’s expectations are again outdone as Bong is posting solid Q3 numbers.
Starkt kvartal med förbättrat förvaltningsresultat Eastnine är ett steg närmare renodling om innehav...
Redeye has a mildly positive take on today’s news that Nanexa has reached a settlement with Vitrivax...
Frånvaron av nya spellanseringar under årets första nio månader har resulterat i en successivt minsk...
Omsättning i linje med estimat Omsättning i kvartalet uppgick till 617 mkr, vilket motsvarar en till...
Rapport i linje med tidigare vinstvarning Nettoomsättningen i kvartalet uppgick till 13,3 mkr, vilke...
Cell Impact mötte ett tufft jämförelsekvartal och minskar både tillväxt samt resultat i Q3.
Infrea presenterar en stark rapport med ökad omsättning och stingande lönsamhet.
Redeye provides its view of SaveLend Group’s quarterly report as a huge step forward towards profita...
Redeye comments on W5 Solutions Q3-results which was above expectations with the company reporting a...
